Literature DB >> 354302

Chronic treatment with LH-RH in golden hamsters.

J Sandow, M Hahn.   

Abstract

Male golden hamsters were treated with low doses (50 or 100 ng) or high doses (500-1000 ng) of LH-RH for periods of 10 to 21 days. Gonadal atrophy was induced by blinding. Treatment of intact hamsters with high doses of LH-RH reduced pituitary sensitivity to a test dose of LH-RH given at the end of the experiment. Concomitantly, testis and seminal vesicles were reduced in weight. In blind hamsters with gonadal atrophy, low dose treatment with LH-RH for 21 days reversed testicular atrophy and restored spermatogenesis, while the high dose treatment partly reversed testicular atrophy (viz. increased tubular diameter) but inhibited spermatogenesis. Low dose treatment also increased testicular and seminal vesicles weight in blinded hamsters, whereas high dose treatment did not change these parameters. It is concluded, that a positive effect on testicular functiion may only be obtained by low dose treatment with LH-RH, whereas high dose treatment induces a negative feedback blocking the effect of LH-RH on pituitary gonadotrophin secretion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 354302     DOI: 10.1530/acta.0.0880601

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

1.  Effects of a potent LHRH-agonist on the pituitary gonadal axis with and without testosterone substitution.

Authors:  J Frick; W Aulitzky
Journal:  Urol Res       Date:  1986

2.  Ultrastructural analysis of the effect of ethane dimethanesulphonate on the testis of the rat, guinea pig, hamster and mouse.

Authors:  J B Kerr; C M Knell; M Abbott; K Donachie
Journal:  Cell Tissue Res       Date:  1987-08       Impact factor: 5.249

3.  Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.

Authors:  B Warner; T J Worgul; J Drago; L Demers; M Dufau; D Max; R J Santen
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.